Developing gene therapy treatments for orphan retinal dystrophies.
Industry: Health Care
First Day Return: +117.4%
Industry: Health Care
IPO Data | |
---|---|
IPO File Date | 12/30/2014 |
Offer Price | $23.00 |
Price Range $19.00 - $21.00 | |
Offer Shares (mm) | 7.0 |
Deal Size ($mm) | $161 |
Lock-Up Date | IPO Pro Only |
Street Research | IPO Pro Only |
IPO Data | |
---|---|
IPO Date | 01/29/2015 |
Offer Price | IPO Intelligence Only |
Price Range | IPO Intelligence Only |
Offer Shares (mm) | IPO Intelligence Only |
Deal Size ($mm) | $161 |
Lock-Up Date | IPO Intelligence Only |
Street Research | IPO Intelligence Only |
Underwriters |
---|
IPO Intelligence Only |
Company Data | |
---|---|
Headquarters | Philadelphia, PA, United States |
Founded | 2013 |
Employees at IPO | 47 |
Website www.sparktx.com |